Microtubule/Tubulin inhibitor, Combretastatin A4, Purity ≥98%

Cat. No.: X24-08-YM224

Microtubule/Tubulin inhibitor, Combretastatin A4, Purity ≥98%

Synonym: 117048-59-6; CRC 87-09; NSC 817373; 2-Methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol

  • MDL: MFCD03453309
  • CAS Number: 117048-59-6
  • Compound CID: 5351344
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Combretastatin A4, soluble in DMSO and warmed ethanol and insoluble in water, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Weight
316.35
Molecular Formula
C18H20O5
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 58 mg/mL (183.34 mM); Water: insoluble; Ethanol (warmed): 31 mg/mL (97.99 mM); In vivo: 5% DMSO + 50% PEG 300 + ddH2O, 28 mg/mL
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Combretastatin A4 is a cytoskeletal signaling inhibitor that plays a key role in disrupting the blood supply to tumors.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.